• Forte Pharma Fortebiotic+ Atb 10 Caps
-48%

Forte Pharma Fortebiotic+ Atb 10 Caps

SKU201148

Forte Pharma Laboratories Fortébiotic+ ATB 10 Capsules. A food supplement that combines 2 microbiotic strains and a yeast that helps to restore the microbiotic balance.

 
Regular price €5,88
Sale price €5,88 Regular price €11,37
You are saving: -€5,49
Forte Pharma Fortebiotic+ Atb 10 Caps
Forte Pharma Fortebiotic+ Atb 10 Caps
Regular price €5,88
Sale price €5,88 Regular price €11,37
You are saving: -€5,49

Fortébiotic+ ATB by Forte Pharma Laboratories is an intestinal treatment formulated with Saccharomyces boulardii yeast (2 billion CFU), together with 2 microbiotic strains Lactobacillus plantarum LP01 and Bifidobacterium breve BR03 (10 billion CFU). The synergy of these active ingredients benefits the balance of the microbiota.

It is formulated with innovative microencapsulated technology, which is gastroresistant, allowing these probiotics to reach the intestine alive ensuring a more effective action. This treatment mitigates the imbalance of the microbiota, responsible for many alterations in our body such as asthma, obesity, fatty liver, irritable bowel among others, contributing to the good bacterial ecosystem.

It does not contain gluten, lactose, egg, soya or phenylalanine.

Who is it suitable for?

Fortébiotic+ ATB by Forte Pharma Laboratories is a treatment indicated for people over 12 years of age.

Do not use in pregnant or breastfeeding women or in children under 12 years of age without prior medical advice.

Directions for use

Take 1 capsule a day with a large glass of water (200 ml). 10-day renewable programme.

Pharmaceutical recommendation

FarmaciasDirect reminds you that food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle. Do not exceed the dosage recommended by the manufacturer. Keep in a cool, dry place out of the reach of children. In case of adverse effects discontinue use and consult a specialist.

Composition

The active ingredients of this treatment are: Saccharomyces boulardii yeast (2 billion CFU), together with 2 microbiotic strains Lactobacillus plantarum LP01 and Bifidobacterium breve BR03 (10 billion CFU).